Structural and functional analysis of lorlatinib analogs reveals roadmap for targeting diverse compound resistance mutations in ALK-positive lung cancer
Aya Shiba‐Ishii(University of Tsukuba), Aaron N. Hata(Harvard University)
Cited by 2
Related Papers
Aberrant Stratifin Overexpression Is Regulated by Tumor-Associated CpG Demethylation in Lung Adenocarcinoma
|American Journal Of Pathology|2012|51
High expression of stratifin is a universal abnormality during the course of malignant progression of early‐stage lung adenocarcinoma
|International Journal of Cancer|2011|50
Identification of Determinants of Ligand Binding Affinity and Selectivity in the Prostaglandin D2 Receptor CRTH2
|Journal of Biological Chemistry|2005|37